- •Retinal Vein Occlusions
- •Preface
- •Acknowledgments
- •Contents
- •1.1 Anatomy and Histology
- •1.2 Microanatomy of the Retina
- •1.3 Vascular Anatomy
- •Bernoulli’s Principle and Deductions Concerning Changes in Central Retinal Vein Diameter at the Lamina Cribrosa
- •1.4 Pathologic Anatomy
- •1.4.1 Abnormalities of the Vessel Wall
- •1.4.2 Branch Retinal Vein Occlusion
- •1.4.3 Central Retinal Vein Occlusion
- •1.4.4 Hemicentral Retinal Vein Occlusion
- •1.5 Summary of Key Points
- •References
- •2.1 Abnormalities of the Blood
- •2.1.1 Thrombosis
- •2.1.2 Viscosity of Blood
- •2.2 Abnormalities of Blood Flow
- •2.2.1 Retinal Vascular Hemodynamics
- •2.2.1.1 Laplace’s Law
- •2.2.1.2 Poiseuille’s Law
- •A Misapplication of Poiseuille’s Law
- •2.2.1.3 Hemodynamics of Central Retinal Vein Occlusion
- •How Severe Must Central Venous Obstruction Be to Produce Symptoms?
- •The Central Retinal Artery in Central Retinal Vein Occlusion
- •2.2.1.4 Hemodynamics of BRVO
- •2.3 Macular Edema
- •2.3.1 Macular Anatomy and Its Relationship to Macular Edema in Retinal Vein Occlusion
- •2.3.2 Starling’s Law
- •2.3.3 The Retinal Pigment Epithelial Pump
- •2.3.4 Molecular Signaling in Macular Edema
- •Relevant Molecular Biologic Terminology
- •2.3.4.1 Vascular Endothelial Growth Factor
- •2.3.4.2 Other Retinal Cytokines with Lesser Roles
- •2.3.4.3 Molecular Signaling in BRVO
- •2.3.4.4 Molecular Signaling in CRVO
- •What Does the Response of RVO to Intravitreal Anti-VEGF Drugs Say About Pathophysiology?
- •2.4 Retinal Neovascularization
- •Spontaneous Venous Pulsations and CRVO
- •2.7 Animal Models of Retinal Vein Occlusion
- •2.7.1 Animal Models of BRVO
- •2.7.2 Animal Models of CRVO
- •2.8 Summary of Key Points
- •2.9 Future Directions
- •References
- •3.1 Background for Clinical Genetics
- •3.2 The Role of Polymorphisms in Genetic Studies
- •3.3 Types of Genetic Study Design
- •Why Are So Many Association Studies for Retinal Vein Occlusion Negative?
- •3.4 Studies of the Genetics of Retinal Vein Occlusion
- •3.4.1 Platelet Glycoprotein Receptor Genes
- •3.4.2.1 Pooled Retinal Vein Occlusion
- •3.4.2.2 Central Retinal Vein Occlusion
- •3.4.2.3 Branch Retinal Vein Occlusion
- •3.4.4 202210G > A Mutation of the Prothrombin Gene (Factor II Leiden)
- •3.4.6 Protein C
- •3.4.7 Protein S
- •3.4.8 Fibrinogen
- •3.4.9 Factor XII
- •3.4.12 Other Negative Genetic Association Studies
- •3.5 Summary of Key Points
- •References
- •4.1 Nosology of Retinal Vein Occlusions
- •4.2 Branch Retinal Vein Occlusion
- •4.3 Central Retinal Vein Occlusion
- •Central Retinal Vein Occlusion with Nonischemic and Ischemic Hemispheres
- •4.3.1 Conversion from Nonischemic to Ischemic Forms of Retinal Vein Occlusion
- •4.4 Summary of Key Points
- •References
- •Quantifying Risk
- •The Major Epidemiologic Studies of Retinal Vein Occlusion
- •5.2 Prevalence
- •5.2.1 Pooled Retinal Vein Occlusion
- •5.2.2 Branch Retinal Vein Occlusion
- •5.2.3 Central Retinal Vein Occlusion
- •5.2.4 Hemicentral Retinal Vein Occlusion
- •5.3 Incidence
- •5.3.1 Pooled Retinal Vein Occlusion
- •5.3.2 Branch Retinal Vein Occlusion
- •5.3.3 Central Retinal Vein Occlusion
- •5.4 Risk and Protective Factors for Retinal Vein Occlusion
- •5.4.1.1 Pooled Retinal Vein Occlusion
- •5.4.1.2 Branch Retinal Vein Occlusion
- •5.4.1.3 Central Retinal Vein Occlusion
- •5.4.1.4 Hemicentral Retinal Vein Occlusion
- •5.4.2 Gender
- •5.4.2.1 Pooled Retinal Vein Occlusion
- •5.4.2.2 Branch Retinal Vein Occlusion
- •5.4.2.3 CRVO
- •5.4.2.4 Hemicentral Retinal Vein Occlusions
- •5.4.3 Race
- •5.4.4 Laterality
- •5.4.5 Body Mass Index
- •5.4.6 Education
- •5.4.7 Physical Activity
- •5.4.8 Miscellaneous Factors Explored and Not Found Important
- •5.5.1 Pooled Retinal Vein Occlusion
- •5.5.2 Branch Retinal Vein Occlusion
- •5.5.3 Central Retinal Vein Occlusion
- •5.5.4 Hemicentral Retinal Vein Occlusion
- •5.6 Life Expectancy
- •5.7 Visual Impact of Retinal Vein Occlusions
- •5.8 Summary of Key Points
- •References
- •6.1 Introduction
- •6.2 Systemic Associations
- •6.2.1 Hypertension
- •6.2.1.1 Pooled Retinal Vein Occlusions
- •6.2.1.2 Branch Retinal Vein Occlusion
- •6.2.1.3 Central Retinal Vein Occlusion
- •6.2.2 Diabetes Mellitus
- •6.2.2.1 Pooled Retinal Vein Occlusion
- •6.2.2.2 Branch Retinal Vein Occlusion
- •6.2.2.3 Central Retinal Vein Occlusion
- •6.2.3 Hyperlipidemia
- •6.2.3.1 Pooled Retinal Vein Occlusions
- •6.2.3.2 Branch Retinal Vein Occlusion
- •6.2.3.3 Central Retinal Vein Occlusion
- •6.2.4 Cardiovascular Disease
- •6.2.4.1 Pooled Retinal Vein Occlusion
- •6.2.4.2 Branch Retinal Vein Occlusion
- •6.2.4.3 Central and Hemicentral Retinal Vein Occlusion
- •6.2.4.4 Stroke
- •6.2.4.5 Carotid Artery Disease and Peripheral Vascular Disease
- •6.2.5 Rheologic and Hematologic Abnormalities
- •6.2.6 Coagulation Abnormalities
- •6.2.6.1 Antiphospholipid Antibodies
- •6.2.6.2 Factor VII
- •6.2.6.3 Factor VIII
- •6.2.6.4 Lipoprotein a
- •6.2.6.5 Von Willebrand Factor
- •6.2.6.6 Other Coagulation Factors
- •6.2.7 Hyperhomocysteinemia
- •6.2.7.1 Pooled Retinal Vein Occlusion
- •6.2.7.2 Branch Retinal Vein Occlusion
- •6.2.7.3 Central and Hemicentral Retinal Vein Occlusion
- •6.2.8 Serum Folate
- •6.2.9 Serum B12
- •6.2.10 Smoking
- •6.2.11 Alcohol Consumption
- •6.2.14 No Underlying Vascular Risk Factor
- •6.3 Ocular Associations
- •6.3.1 Pooled Retinal Vein Occlusion
- •6.3.2 Branch Retinal Vein Occlusion
- •6.3.3 Central Retinal Vein Occlusion and Hemicentral Retinal Vein Occlusion
- •6.4 Practical Recommendations About the Systemic Workup of Patients with Retinal Vein Occlusion
- •History of the Standard Workup for Systemic Associations in Central Retinal Vein Occlusion
- •6.5 Retinal Vein Occlusion and Cardiovascular Disease Risk
- •6.6 Differences in Systemic Associations Between Ischemic and Nonischemic CRVOs
- •6.7 Summary of Key Points
- •References
- •7.1 Branch Retinal Vein Occlusion
- •7.1.1 Acute Phase
- •7.1.1.1 Symptoms
- •7.1.2 Clinical Signs
- •7.1.2.1 Visual Acuity
- •7.1.3 Chronic Phase
- •7.1.3.1 Clinical Signs
- •7.1.3.2 Visual Acuity
- •Why Does the Visual Outcome in Nonischemic, Macula-Involving Branch Retinal Vein Occlusions Usually Vary with the Size of the Involved Retina?
- •7.2 Central Retinal Vein Occlusion
- •7.2.1 Acute Phase
- •7.2.1.1 Symptoms
- •7.2.1.2 Clinical Signs
- •When Retinal Venous Congestion and Optic Disc Edema Are Not Central Retinal Vein Occlusion
- •What Is the Relationship of Central Retinal Artery Pressure and Cilioretinal Artery Pressure?
- •Retinal Whitening Does Not Equal Infarction
- •A Clinical Picture Predicted by a Hypothesis
- •7.2.1.3 Visual Acuity
- •7.2.2 Chronic Phase
- •Why Are Optic Disc Collaterals Associated with Worse Initial and Final Visual Acuity After CRVO?
- •7.2.2.1 Visual Acuity
- •7.3 Hemicentral Retinal Vein Occlusion
- •7.3.1 Clinical Signs
- •7.3.2 Visual Acuity
- •7.4 Summary of Key Points
- •References
- •Which Measure of Reproducibility Is Best?
- •8.1 Color Fundus Photography
- •8.2 Fluorescein Angiography
- •8.2.1 Branch Retinal Vein Occlusion
- •8.2.2 Central Retinal Vein Occlusion
- •8.3 Optical Coherence Tomography and the Retinal Thickness Analyzer
- •Methods of Analysis of OCT in RVO
- •8.4 Visual Field Testing
- •8.5 Electroretinography
- •Electroretinography Essentials for Retinal Vein Occlusions
- •8.5.1 Branch Retinal Vein Occlusion
- •8.5.2 Central Retinal Vein Occlusion
- •8.5.3 Hemicentral Retinal Vein Occlusion
- •8.6 Indocyanine Green Angiography
- •8.7 Color Doppler Ultrasonographic Imaging
- •8.8 Laser Doppler Flowmetry
- •8.9 Ophthalmodynamometry
- •8.10 Scanning Laser Doppler Flowmetry
- •8.11 Laser Interferometry to Measure Pulsatile Choroidal Blood Flow
- •8.12 Vitreous Fluorophotometry
- •8.13 Summary of Key Points
- •References
- •9.1 Terminology
- •9.2 Branch Retinal Vein Occlusion
- •9.3 Central Retinal Vein Occlusion
- •9.3.1 Clinical Characteristics
- •In the Face of Evidence that Fluorescein Angiography Is Poorly Predictive of Ischemia in Acute Central Retinal Vein Occlusion, Why Is It Widely Used?
- •9.3.2 Conversion from Nonischemic to Ischemic Central Retinal Vein Occlusion
- •9.3.3 Outcomes by Ischemic Status
- •9.4 Interaction of Ischemia with Effects of Treatments
- •9.4.1 Branch Retinal Vein Occlusion
- •9.4.2 Central Retinal Vein Occlusion
- •9.5 Summary of Key Points
- •References
- •10.1 Branch Retinal Vein Occlusion
- •10.2 Central Retinal Vein Occlusion
- •10.3 Hemicentral Retinal Vein Occlusion
- •10.4 Treatment of Posterior Segment Neovascularization in Retinal Vein Occlusion
- •10.5 Summary of Key Points
- •References
- •11.1 The Pathoanatomy and Pathophysiology of Iris and Angle Neovascularization
- •11.2 Clinical Picture of Anterior Segment Neovascularization
- •11.4 Anterior Segment Neovascularization in Branch Retinal Vein Occlusion
- •11.5 Anterior Segment Neovascularization in Central Retinal Vein Occlusion
- •The Problem of Undetected Anterior Segment Neovascularization After Central Retinal Vein Occlusion
- •Why Is Anterior Segment Neovascularization Less Common in Central Retinal Vein Occlusion Than in Central Retinal Artery Occlusion?
- •11.6 Anterior Segment Neovascularization in Hemicentral Retinal Vein Occlusion
- •11.7 Summary of Key Points
- •References
- •12.1 Branch Retinal Vein Occlusion with Macular Edema
- •12.2 Central Retinal Vein Occlusion with Macular Edema
- •12.3 Summary of Key Points
- •References
- •Visual Acuity Measurement in Treatment Studies
- •OCT Measurement of Macular Thickness in Treatment Studies
- •13.1 Medical Treatment of Retinal Vein Occlusion
- •13.1.1 Anticoagulation
- •13.1.2 Systemic Thrombolytic Therapy
- •13.1.3 Isovolumic Hemodilution
- •Recipe for Isovolumic Hemodilution
- •13.1.4 Plasmapheresis
- •13.2 Treatment of Previously Unsuspected Risk Factors for Retinal Vein Occlusion
- •13.3.1 Treatments for Macular Edema
- •Relative Corticosteroid Potencies
- •13.3.2 Treatments for Intraocular Neovascularization
- •13.4 Results of Clinical Studies of Treatments for Macular Edema Secondary to Retinal Vein Occlusions
- •13.4.1 Branch Retinal Vein Occlusion
- •13.4.1.1 Grid Laser
- •13.4.1.2 Subthreshold Grid Laser Treatment
- •13.4.1.3 Sector Panretinal Laser Photocoagulation
- •13.4.1.5 Posterior Subtenon’s Triamcinolone
- •13.4.1.6 Intravitreal Corticosteroids
- •13.4.1.7 Combination Treatments Involving Intravitreal Triamcinolone Injections
- •13.4.1.8 Arteriovenous Sheathotomy
- •13.4.1.9 Vitrectomy
- •13.4.1.10 Intravitreal Injection of Autologous Plasmin
- •13.4.2 Central Retinal Vein Occlusion
- •13.4.2.2 Combination Regimen: Bevacizumab, Panretinal Laser, and Grid Laser
- •13.4.2.3 Systemic Corticosteroids
- •13.4.2.4 Posterior Subtenon’s Triamcinolone Injection
- •13.4.2.5 Intravitreal Corticosteroids
- •13.4.2.6 Vitrectomy
- •13.5 Treatment of Intraocular Neovascularization
- •13.5.1 Sector Panretinal Laser Photocoagulation for Retinal and Disc Neovascularization After Branch Retinal Vein Occlusion
- •13.5.2 Vitrectomy for Intraocular Neovascularization with Vitreous Hemorrhage
- •13.5.3 Laser Panretinal Photocoagulation for Anterior Segment Neovascularization
- •13.6 Economic Considerations
- •13.7 Future Directions
- •13.8 Summary of Key Points
- •References
- •14.1 Pooled Retinal Vein Occlusions in the Young
- •14.2 Branch Retinal Vein Occlusion in Younger Patients
- •14.3 Central Retinal Vein Occlusion in Younger Patients
- •14.4 Workup in the Younger Patient with Retinal Vein Occlusion
- •14.5 Summary of Key Points
- •References
- •15.1 Failed and Unadopted Treatments for Branch Retinal Vein Occlusion
- •15.1.1 Sector Panretinal Laser Photocoagulation for Serous Retinal Detachment in Branch Retinal Vein Occlusion
- •15.1.2 Laser Chorioretinal Venous Anastomosis for Branch Retinal Vein Occlusion with Macular Edema
- •15.1.3 Intravenous Infusion of Tissue Plasminogen Activator
- •15.1.4 Intravitreal Injection of Tissue Plasminogen Activator
- •15.1.5 Macular Puncture for Branch Retinal Vein Occlusion with Macular Edema
- •15.2 Failed and Unadopted Treatments for Central Retinal Vein Occlusion
- •15.2.1 Grid Laser for Macular Edema in Central Retinal Vein Occlusion
- •15.2.2 Chorioretinal Venous Anastomosis for Nonischemic Central Retinal Vein Occlusion with Macular Edema
- •15.2.3 Radial Optic Neurotomy for Central Retinal Vein Occlusion
- •15.2.4 Retinal Endovascular Surgery with Intravenous Injection of Tissue Plasminogen Activator
- •15.2.5 Intravitreal Injection of Tissue Plasminogen Activator
- •15.2.6 Intravitreal Tissue Plasminogen Activator and Triamcinolone
- •15.2.7 Systemic Acetazolamide for Central Retinal Vein Occlusion with ME
- •15.2.8 Combined Central Retinal Vein Occlusion and Central Retinal Artery Occlusion
- •15.2.9 Optic Nerve Sheath Decompression
- •15.2.10 Section of the Posterior Scleral Ring
- •15.2.11 Infusion of High Molecular Weight Dextran
- •15.3 Failed and Unadopted Treatments for HCRVO
- •15.4 Summary of Key Points
- •References
- •16.1 Case 16.1: An Asymptomatic Central Retinal Vein Occlusion with Asymmetric Hemispheric Involvement
- •16.1.1 Discussion
- •16.2 Case 16.2: Chronic Macular Branch Vein Occlusion with Subtle Ophthalmoscopic Signs, More Obvious Fluorescein Angiographic Signs, and Macular Edema
- •16.2.1 Discussion
- •16.3 Case 16.3: Old Hemicentral Retinal Vein Occlusion with Late Vitreous Hemorrhage and Hyphema
- •16.3.1 Discussion
- •16.4 Case 16.4: Spontaneous Improvement of a Nonischemic Central Retinal Vein Occlusion
- •16.4.1 Discussion
- •16.5 Case 16.5: Conversion of a Nonischemic Hemicentral Retinal Vein Occlusion to an Ischemic One
- •16.5.1 Discussion
- •16.6 Case 16.6: Nonarteritic Ischemic Optic Neuropathy Following Branch Retinal Vein Occlusion
- •16.6.1 Discussion
- •16.7 Case 16.7: Differentiating Central Retinal Vein Occlusion from the Ischemic Ocular Syndrome
- •16.7.1 Discussion
- •16.8 Case 16.8: Late Development of Neovascularization Elsewhere After Ischemic Branch Retinal Vein Occlusion
- •16.8.1 Discussion
- •16.9 Case 16.9: Nonischemic Central Retinal Vein Occlusion with Secondary Branch Retinal Artery Occlusion
- •16.9.1 Discussion
- •16.10 Case 16.10: Nonischemic Central Retinal Vein Occlusion with Macular Edema or Asymmetric Diabetic Retinopathy with Diabetic Macular Edema?
- •16.10.1 Discussion
- •16.11 Summary of Key Points
- •References
- •Index
Acknowledgments
I am indebted to many friends and colleagues who helped in writing this book. Will Doak was indispensable as an editor, streamlining convoluted sentences and pointing out simpler words when more complicated ones were written. Stephen Clark meticulously prepared references, obtained permissions to reproduce figures, checked facts, and gathered materials for the illustrations. Vignesh Balasubramanian worked diligently to retrieve references. Clare Browning and Gabriela Ritterspach read drafts critically and pointed out mistakes and infelicities of expression. The excellent artist at Springer, Sara Krause, CMI, transformed rough sketches and requests for illustrations into clear diagrams. Joanna Perey and Rebekah Amos of Springer were unfailingly helpful and prompt in facilitating workflow throughout the project. Mike McOwen, Lorraine Clark, Uma Balasubramanian, and Donna Jo McLain took all the retinal photographs and optical coherence tomography images used in the book. I am reminded of their skills every day in the clinic. I especially thank Clare Browning for her support and wit throughout.
xi
Contents
1 |
Anatomy and Pathologic Anatomy of Retinal |
|
|
Vein Occlusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
1 |
2 |
Pathophysiology of Retinal Vein Occlusions. . . . . . . . . . . . . . |
33 |
3 |
Genetics of Retinal Vein Occlusions . . . . . . . . . . . . . . . . . . . . |
73 |
4 |
Classification of Retinal Vein Occlusion . . . . . . . . . . . . . . . . . |
95 |
5 |
Epidemiology of Retinal Vein Occlusions . . . . . . . . . . . . . . . . |
107 |
6 |
Systemic and Ocular Associations |
|
|
of Retinal Vein Occlusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
125 |
7 |
The Clinical Picture and Natural History |
|
|
of Retinal Vein Occlusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
159 |
8 |
Ancillary Testing in the Management |
|
|
of Retinal Vein Occlusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
195 |
9 |
Ischemia and Retinal Vein Occlusions . . . . . . . . . . . . . . . . . . |
223 |
10 |
Posterior Segment Neovascularization |
|
|
in Retinal Vein Occlusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
241 |
11 |
Anterior Segment Neovascularization |
|
|
in Retinal Vein Occlusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
249 |
12 |
Macular Edema in Retinal Vein Occlusion. . . . . . . . . . . . . . . |
265 |
13 |
Treatment of Retinal Vein Occlusions. . . . . . . . . . . . . . . . . . . |
279 |
14 |
Retinal Vein Occlusions in the Young . . . . . . . . . . . . . . . . . . . |
335 |
15 |
Failed and Unadopted Treatments |
|
|
for Retinal Vein Occlusions . . . . . . . . . . . . . . . . . . . . . . . . . . . |
345 |
16 |
Case Studies in Retinal Vein Occlusion. . . . . . . . . . . . . . . . . . |
359 |
Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
379 |
|
xiii
Chapter 1
Anatomy and Pathologic Anatomy
of Retinal Vein Occlusions
There are three types of retinal vein occlusions (RVO): branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO), and hemicentral retinal vein occlusion (HCRVO). The causes of all three types of retinal vein occlusions are multifactorial, involve diverse anatomic conÞgurations and physiologic pathways, and may differ in each instance of occlusion.
There are both predisposing and precipitating factors for RVO.1 For example, a predisposing factor might be atherosclerotic disease of the central retinal artery or primary open-angle glaucoma.2 A precipitating factor might be acute dehydration and elevated serum viscosity associated with a viral infection. The consequences of RVO are also variable. They depend on the relevant anatomy and can involve the clotting cascade, vascular physiology, and the biochemistry of the bloodÐretina barrier.
This chapter focuses on aspects of ocular anatomy pertinent to the understanding of RVO, and on the pathologic anatomy of RVO. The next chapter focuses on relevant ocular physiology and the pathophysiology of RVO. For clarity, an arbitrary distinction between anatomy and physiology will not be made. For example, a natural place to present BernoulliÕs principle, a physiologic concept, will be in the present chapter along with the discussion of the anatomic aspect of the central retinal vein as it narrows in its passage through the lamina cribrosa. Likewise, the biochemical pathways involving homocysteine metabolism are most relevant to the pathology of atherosclerosis, a pathologic process covered in
this chapter. On the other hand, the absence of sympathetic innervation of retinal vessels is more appropriately discussed along with the physiologic concept of autoregulation in the next chapter.
Commonly used abbreviations in this chapter are collected in Table 1.1 for reference. In addition, each abbreviation will be introduced with its spelled out term at the Þrst use of the term in the chapter.
1.1 Anatomy and Histology
At the gross anatomic level, the axial length of the eye and the diameter of the scleral outlet have been hypothesized to be relevant to the pathogenesis of CRVO.3 The axial length of eyes with CRVO is signiÞcantly shorter than fellow eyes and eyes of healthy controls suggesting that a short eye increases risk for CRVO (Table 1.2).3,7,9 Whether axial length is shorter in eyes with BRVO is less certain (Table 1.2). Three of Þve studies report shorter mean lengths for eyes with BRVO compared to fellow eyes. Five of six studies report shorter mean lengths for eyes with BRVO compared to eyes from healthy con- trols.3,5-9 A study measuring the scleral outlet of eyes with CRVO and comparing it to controls has not been done, but a smaller diameter sclera outlet has been hypothesized to increase risk for CRVO.3 The hypothesized mechanism is that
D.J. Browning, Retinal Vein Occlusions, DOI 10.1007/978-1-4614-3439-9_1, |
1 |
© Springer Science+Business Media New York 2012 |
|
2 |
1 Anatomy and Pathologic Anatomy of Retinal Vein Occlusions |
Table 1.1 Abbreviations used in anatomy and pathologic anatomy of retinal vein occlusions
Abbreviation |
Term |
AV |
Arteriovenous |
BRVO |
Branch retinal vein occlusion |
BM |
BruchÕs membrane |
CRVO |
Central retinal vein occlusion |
C |
Choroid |
CRA |
Central retinal artery |
CRV |
Central retinal vein |
ELM |
External limiting membrane |
FAZ |
Foveal avascular zone |
FA |
Fluorescein angiogram |
GCL |
Ganglion cell layer |
HCRV |
Hemicentral retinal vein |
HCRVO |
Hemicentral retinal vein occlusion |
I |
Inferior |
INL |
Inner nuclear layer |
IPL |
Inner plexiform layer |
IS/OS |
Inner segment/outer segment |
mMicron
nm |
Nanometer |
N |
Nasal |
NFL |
Nerve Þber layer |
OCT |
Optical coherence tomography |
ONL |
Outer nuclear layer |
OPL |
Outer plexiform layer |
ONL |
Outer nuclear layer |
PVD |
Posterior vitreous detachment |
RPE |
Retinal pigment epithelium |
RVO |
Retinal vein occlusion |
RPC |
Radial peripapillary capillaries |
SSuperior
TTemporal
VEGF |
Vascular endothelial growth factor |
Table 1.2 Axial length of the eye in retinal vein occlusion
shorter eyes are associated with crowding of the central retinal vein (CRV) and central retinal artery (CRA) as they pass through the lamina cribrosa, leading to increased venous blood ßow turbulence.7,9
Histologically, the retina is a multilayered sheet of neuronal, glial, and vascular tissue that lines the inside posterior two-thirds of the eye. It is bounded posteriorly by the retinal pigment epithelium, BruchÕs membrane, and choroid and anteriorly by the vitreous humor. The macula is a circular area of diameter 5.5 mm with a center located 17¡, or 4.0Ð5.0 mm, temporal, and 0.53Ð 0.8 mm inferior to the center of the optic disc (Fig. 1.1).11-13 Among its distinguishing features are the high density of cones, ³2 layers of ganglion cells, and xanthophyll pigment within bipolar and ganglion cells.11,12 The central 1.5-mm circular area of the macula is the fovea, denoted by a gently curved depression in the retinal surface. Within the fovea is a roughly circular avascular area, the foveal avascular zone, approximately 400Ð500 m in diameter which contains only cones, present at a density of approximately 140,000/mm2.11
A cross section through the retina just outside the area centralis shows ten layers (Figs. 1.2 and 1.3). Proceeding from the vitreous to the choroid are the internal limiting membrane, nerve Þber layer, ganglion cell layer, inner plexiform layer, inner nuclear layer, outer plexiform layer, outer
|
|
Axial length |
Axial length |
Axial length |
|
||
Study |
Type RVO/N |
RVO eyes |
fellow eyes |
control eyes |
P |
||
|
|
|
|
|
|
|
|
Timmerman et al.4 |
BRVO/24/24 |
22.76 ± 0.92 |
22.80 |
± 0.86* |
23.36 |
± 1.08** |
0.26*; 0.023** |
Simons and Brucker5 |
BRVO/36/36 |
23.55 ± 0.96 |
|
|
23.62 |
± 1.37 |
0.79 |
Goldstein et al.6 |
BRVO/24 |
22.82 ± 0.94 |
23.05 |
± 0.87 |
|
|
0.037 |
Ariturk et al.3 |
BRVO/41/66 |
22.89 ± 0.11 |
22.99 |
± 0.12* |
23.22 |
± 0.09** |
>0.05*; <0.05** |
Mehdizadeh et al.7 |
BRVO/18/18 |
22.52 ± 0.72 |
22.77 |
± 0.64* |
23.77 |
± 1.02** |
0.048*; 0.0002** |
Talu and Stefanut8 |
BRVO/18/18 |
22.42 (range |
22.44 (range |
23.42 (range |
0.776*; 0.00064** |
||
|
|
21.5Ð24.1) |
21.3Ð24.2)* |
21.5Ð24.4)** |
|
||
Tsai et al.9 |
BRVO/77/67 |
23.13 ± 0.86 |
23.32 |
± 1.02* |
23.98 |
± 0.84** |
0.02*; <0.05** |
Ariturk et al.3 |
CRVO/17 |
22.25 ± 0.19 |
22.61 |
± 0.13* |
23.22 |
± 0.09** |
<0.05*; <0.001** |
Tsai et al.9 |
CRVO/40/67 |
23.22 ± 1.14 |
23.48 |
± 1.01* |
23.98 |
± 0.84** |
0.05*; <0.05** |
Mehdizadeh et al.7 |
CRVO/18/18 |
22.71 ± 0.85 |
23.23 |
± 0.71* |
23.77 |
± 1.02** |
0.007*; 0.0018** |
BRVO branch retinal vein occlusion, CRVO central retinal vein occlusion, RVO retinal vein occlusion, N number of subjects
*P value compared to fellow eyes; **P value compared to control eyes
